[india-drug] Response to EDL at PHC

["Dr.Thatte" <mthatte@vsnl.com>]

Response to EDL at PHC
----------------------
Sender: owner-india-drug@usa.healthnet.org
Precedence: bulk
Reply-To: india-drug@usa.healthnet.org


The point about the importance of a Drugs and Therapeutic Committee and
periodic review made by Dr. Sudarshan is very valid. 

The importance of a dynamic process of selection of drugs on the EDL as
well as a scientific basis for quantification of needs is obvious. The
efforts taken in this direction especially by a DTC will always be
rewarding.
 
Dr. Urmila Thatte
Dept. of Clinical Pharmacology
BYL Nair Hospital
Mumbai 400 008
Tel. 91 22 305 0347; 301 4713;
         91 22 308 1490 ext 205
Fax  91 22 307 5243
e-mail clinpharm@vsnl.net



________________________________________________________________________
For live cricket scores download  Yahoo! Score Tracker
 at: http://in.sports.yahoo.com/cricket/tracker.html
The INDIA-DRUG discussion group is a partnership between SATELLIFE
(www.healthnet.org), WHO Essential Drugs and Medicines Policy
(www.who.ch), and the Delhi Society for the Promotion of the
Rational Use of Drugs (DSPRUD) in India.

To send a message to india-drug, write to: india-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe india-drug OR unsubscribe india-drug
To contact a person, send a message to: india-drug-help@usa.healthnet.org